1. Volume 6, Issue 6, Pages 369-376 (June 2005)
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial 
Dr Michele Reni, MD, Stefano Cordio, MD, Carlo Milandri, MD, Paolo Passoni, MD, Elisa Bonetto, MD, Cristina Oliani, MD, Gabriele Luppi, MD, Roberto Nicoletti, MD, Laura Galli, MSc, Roberto Bordonaro, MD, Alessandro Passardi, MD, Alessandro Zerbi, MD, Gianpaolo Balzano, MD, Luca Aldrighetti, MD, Prof Carlo Staudacher, MD, Eugenio Villa, MD, Prof Valerio Di Carlo, MD 
The Lancet Oncology 
Volume 6, Issue 6, Pages (June 2005)
DOI: /S (05)
Copyright © 2005 Elsevier Ltd Terms and Conditions

2. Figure 1
Trial profile
The Lancet Oncology 2005 6, DOI: ( /S (05) )
Copyright © 2005 Elsevier Ltd Terms and Conditions

3. Figure 2 Progression-free survival
*One patient died 1 week after randomisation and before starting treatment.
The Lancet Oncology 2005 6, DOI: ( /S (05) )
Copyright © 2005 Elsevier Ltd Terms and Conditions

4. Figure 3 Overall survival
*One patient died 1 week after randomisation before starting treatment.
The Lancet Oncology 2005 6, DOI: ( /S (05) )
Copyright © 2005 Elsevier Ltd Terms and Conditions